FTC sues major pharmacy reward professionals about insulin selling prices The company brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist cost of lifetime-conserving insulin medication. Listen to the report 10 min This audio is vehicle-generated. Make sure you https://emiliouvspp.jaiblogs.com/57658161/about-healthcare-news